Angiodynamics ANGO
NASDAQ ANGO
$12.42 +0.35 (+2.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Angiodynamics (ANGO) Selling, General & Administrative (2009 - 2026)

Updated

Angiodynamics' Selling, General & Administrative was $12.47 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), down 0.7% from $12.56 million a year earlier but up 21.4% from the prior quarter.

Analysis

Angiodynamics (ANGO) Selling, General & Administrative (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Angiodynamics' Selling, General & Administrative was $43.6 million through Aug 31, 2026, down 0.2% year-over-year; for FY2026 (ended May 31, 2026), it came in at $43.69 million, up 3.8% from FY2025.

  • Selling, General & Administrative has now increased for five consecutive fiscal years, with a five-year compound annual growth rate of 4.0% (FY2021 to FY2026).
  • In earlier fiscal years, Selling, General & Administrative was $42.09 million in FY2025 (+2.3%), $41.16 million in FY2024 (+2.9%), $40 million in FY2023 (+4.0%) and $38.45 million in FY2022 (+7.1%).
  • Quarterly Selling, General & Administrative has moved between $8.73 million (fiscal Q3 2022) and $12.56 million (fiscal Q1 2026) over five years.
  • Compared with a year earlier, Selling, General & Administrative was higher in four of the last eight quarters, with growth averaging 2.9%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q4 2022 (growth of 21.6%); the worst was fiscal Q2 2024 (a decline of 14.3%).
  • Per Business Quant data, ANGO's Selling, General & Administrative in the three fiscal quarters before Q1 2027 was $10.27 million (Q4 2026), $10.72 million (Q3 2026) and $10.15 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 2.32 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 4.27 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 2.16 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 633.40 Mn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 3.20 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 2.31 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 1.68 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 560.90 Mn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 1.26 Bn
10 Angiodynamics 20.48 Mn -146.80 Mn 48.04 Mn 12.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 12.47 Mn
May 31, 2026 10.27 Mn
Feb 28, 2026 10.72 Mn
Nov 30, 2025 10.15 Mn
Aug 31, 2025 12.56 Mn
May 31, 2025 10.24 Mn
Feb 28, 2025 10.49 Mn
Nov 30, 2024 10.39 Mn
Aug 31, 2024 10.98 Mn
May 31, 2024 10.44 Mn
Feb 29, 2024 10.58 Mn
Nov 30, 2023 9.29 Mn
Aug 31, 2023 10.86 Mn
May 31, 2023 10.23 Mn
Feb 28, 2023 8.84 Mn
Nov 30, 2022 10.84 Mn
Aug 31, 2022 10.10 Mn
May 31, 2022 11.10 Mn
Feb 28, 2022 8.73 Mn
Nov 30, 2021 9.68 Mn
API Access

Angiodynamics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANGO&period=max&api_key=YOUR_API_KEY